Wells Fargo
SCNI

Wells Fargo’s Scinai Immunotherapeutics SCNI Stock Holding History

Wells Fargo’s Portfolio SCNI Stock Details SCNI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-2
Closed -$12 – 7684
2023
Q4 		$12 Hold
2
– – ﹤0.01% 7348
2023
Q3 		$17 Hold
2
– – ﹤0.01% 7266
2023
Q2 		$28 Hold
2
– – ﹤0.01% 7216
2023
Q1 		$43 Hold
2
– – ﹤0.01% 7148
2022
Q4 		$59 Hold
2
– – ﹤0.01% 6960
2022
Q3 		$0 Hold
2
– – ﹤0.01% 7260
2022
Q2 		$0 Hold
2
– – ﹤0.01% 7391
2022
Q1 		$0 Hold
2
– – ﹤0.01% 7708
2021
Q4 		$0 Sell
2
-1
-33% -$206 ﹤0.01% 7721
2021
Q3 		$1K Hold
3
– – ﹤0.01% 6782
2021
Q2 		$1K Sell
3
-6
-67% -$1.87K ﹤0.01% 6724
2021
Q1 		$3K Sell
9
-8
-47% -$3.49K ﹤0.01% 6594
2020
Q4 		$5K Sell
17
-21
-55% -$25.4K ﹤0.01% 6150
2020
Q3 		$147K Buy
38
+26
+217% +$99.8K ﹤0.01% 5105
2020
Q2 		$27K Buy
12
+3
+33% +$4.83K ﹤0.01% 5636
2020
Q1 		$7K Hold
9
– – ﹤0.01% 5818
2019
Q4 		$8K Hold
9
– – ﹤0.01% 5952
2019
Q3 		$5K Hold
9
– – ﹤0.01% 6067
2019
Q2 		$5K Hold
9
– – ﹤0.01% 6038
2019
Q1 		$5K Hold
9
– – ﹤0.01% 5747
2018
Q4 		$4K Hold
9
– – ﹤0.01% 6110
2018
Q3 		$5K Hold
9
– – ﹤0.01% 6123
2018
Q2 		$6K Hold
9
– – ﹤0.01% 6062
2018
Q1 		$5K Sell
9
-1
-10% -$624 ﹤0.01% 6066
2017
Q4 		$5K Hold
10
– – ﹤0.01% 6057
2017
Q3 		$7K Buy
10
+3
+43% +$2.46K ﹤0.01% 5953
2017
Q2 		$6K Buy
+7
New +$5.15K ﹤0.01% 5885

Other funds holding SCNI

SM
Sabby Management Miami Beach, Florida $45.1M AUM 74.25% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
RhumbLine Advisers
RhumbLine Advisers Boston, Massachusetts $117B AUM 29.66% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
Credit Agricole
Credit Agricole Montrouge Cedex, France $38.1B AUM
MSG
Main Street Group Glen Allen, Virginia $429M AUM 34.03% 1-Year Est. Return
APC
Aspire Private Capital Cornelius, North Carolina $484M AUM 17.28% 1-Year Est. Return

Wells Fargo's SCNI Position: Q1 2024 in Review

Wells Fargo sold out of Scinai Immunotherapeutics (SCNI) in Q1 2024, closing a stake of 2 shares — an estimated $12 sold.

Wells Fargo first reported a position in SCNI in Q2 2017 and held it in 27 quarters. The position peaked at $147K in Q3 2020. 12 funds tracked by Wall St. Rank hold SCNI as of Q1 2024.

  • Wells Fargo reported no remaining Scinai Immunotherapeutics position as of Q1 2024 after selling out during the quarter.
  • Wells Fargo sold 2 Scinai Immunotherapeutics shares in Q1 2024, an estimated $12.
  • Wells Fargo first reported a position in Scinai Immunotherapeutics in Q2 2017 and held it in 27 quarters.
  • Wells Fargo's Scinai Immunotherapeutics position peaked at $147K in Q3 2020.
  • 12 funds tracked by Wall St. Rank held Scinai Immunotherapeutics as of Q1 2024.

Based on Wells Fargo's 13F filing for Q1 2024, filed 10 May 2024.